Venkataraman Balasubramanian

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545454 [patent_doc_number] => 08053426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/984331 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053426.pdf [firstpage_image] =>[orig_patent_app_number] => 11984331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903604 [patent_doc_number] => 20080113017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'STEROL DERIVATIVES, LIPOSOMES COMPRISING STEROL DERIVATIVES AND METHOD OF LOADING LIPOSOMES WITH ACTIVE SUBSTANCES' [patent_app_type] => utility [patent_app_number] => 11/934147 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6507 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113017.pdf [firstpage_image] =>[orig_patent_app_number] => 11934147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11297806 [patent_doc_number] => 09505800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Extended triterpene derivatives' [patent_app_type] => utility [patent_app_number] => 12/513454 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 74846 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12513454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360864 [patent_doc_number] => 20100087539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'N\'--3-AMINO-3-PHENYLPROPEONIC ACID AND THE PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF, A METHOD FOR THE PRODUCTION AND THE USE THEREOF IN THE FORM OF A MEDICINAL AGENT' [patent_app_type] => utility [patent_app_number] => 12/445368 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8254 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087539.pdf [firstpage_image] =>[orig_patent_app_number] => 12445368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164568 [patent_doc_number] => 08173628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Steroidal antiestrogens and antiandrogens and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/975727 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 38977 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173628.pdf [firstpage_image] =>[orig_patent_app_number] => 11975727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586001 [patent_doc_number] => 20090105203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'COMPOUNDS FOR TREATING VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 11/873342 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58110 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105203.pdf [firstpage_image] =>[orig_patent_app_number] => 11873342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196843 [patent_doc_number] => 07638508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Glucocorticosteroid compound having anti-inflammatory activity' [patent_app_type] => utility [patent_app_number] => 11/863390 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12832 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638508.pdf [firstpage_image] =>[orig_patent_app_number] => 11863390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910464 [patent_doc_number] => 20080021231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 11/863419 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12833 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021231.pdf [firstpage_image] =>[orig_patent_app_number] => 11863419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922565 [patent_doc_number] => 20080070881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Prostate Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 11/862153 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16875 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070881.pdf [firstpage_image] =>[orig_patent_app_number] => 11862153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939596 [patent_doc_number] => 20080076915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Epoxidation of 17-oxo-15,16-Methylene Steroids with Sulfoxonium Ylides' [patent_app_type] => utility [patent_app_number] => 11/858976 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2416 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076915.pdf [firstpage_image] =>[orig_patent_app_number] => 11858976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540617 [patent_doc_number] => 08058460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Near infrared fluorophore for the selective labelling of membranes in cells' [patent_app_type] => utility [patent_app_number] => 12/442876 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 4541 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058460.pdf [firstpage_image] =>[orig_patent_app_number] => 12442876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867472 [patent_doc_number] => 20080146531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Therapeutically Active Triazoles and Their Use' [patent_app_type] => utility [patent_app_number] => 11/856768 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36709 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146531.pdf [firstpage_image] =>[orig_patent_app_number] => 11856768 [rel_patent_id] =>[rel_patent_doc_number] =>)